These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16794672)

  • 1. [Reimbursement prescription system in poor state?].
    Sundar T; Thuestad AB; Thomassen PT; Røshol H; Hjelme K; Andestad U; Bryn E
    Tidsskr Nor Laegeforen; 2006 Jun; 126(13):1759-61. PubMed ID: 16794672
    [No Abstract]   [Full Text] [Related]  

  • 2. Financial barriers to implementing combination vaccines: perspectives from pediatricians and policy makers.
    Gidengil CA; Rusinak D; Allred NJ; Luff D; Lee GM; Lieu TA
    Clin Pediatr (Phila); 2009 Jun; 48(5):539-47. PubMed ID: 19318705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in prescribing behaviors after implementing drug reimbursement rate reduction policy in Taiwan: implications for the medicare system.
    Chu HL; Liu SZ; Romeis JC
    J Health Care Finance; 2008; 34(3):45-54. PubMed ID: 18468378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Physicians' experience with increased use of individual reimbursement for pharmaceuticals].
    Levorsen A; Kristiansen IS; Aasland OG
    Tidsskr Nor Laegeforen; 2008 Aug; 128(16):1829-32. PubMed ID: 18787593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug utilization decisions should be based on cost-benefit data].
    Bengt J; Arvidsson G; Levin LA; Rehnberg C
    Lakartidningen; 2005 Apr 18-24; 102(16):1264-5; discussion 1265. PubMed ID: 15921102
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug policy: the challenge is to overcome fragmentation.
    McFarlance A
    Healthc Pap; 2002; 3(1):38-42: discussion 87-94. PubMed ID: 12811109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Policies concerning pharmaceutical prices and reimbursement in Mexico, Organization for Co-operation and Economic Development. 2007].
    Moïse P; Docteur E
    Salud Publica Mex; 2008; 50 Suppl 4():S504-10. PubMed ID: 19082262
    [No Abstract]   [Full Text] [Related]  

  • 8. Differences in the cost of antidepressants across state Medicaid programs.
    Kelton CM; Rebelein RP; Heaton PC; Ferrand Y; Guo JJ
    J Ment Health Policy Econ; 2008 Mar; 11(1):33-47. PubMed ID: 18424875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [How important is prescription of generic preparations?].
    Cronlund A
    Lakartidningen; 2005 Aug 8-21; 102(32-33):2241. PubMed ID: 16145886
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drug politics--economic view-point of a practitioner].
    Băicuş C; Chivu R
    Rev Med Chir Soc Med Nat Iasi; 2004; 108(3):674-8. PubMed ID: 15832997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Decisions by the state, county council's money and my patient. Consequences of the LFN survey of antihypertensive agents].
    André M; Andersén-Karlsson E; Landahl S; Löfmark R; Silfverhielm B; Skoglund I
    Lakartidningen; 2008 May 21-27; 105(21):1549-50. PubMed ID: 18574990
    [No Abstract]   [Full Text] [Related]  

  • 12. Health care policy: marginal vs average cost reimbursement.
    Shahinian L
    Ophthalmic Surg; 1993 Oct; 24(10):711. PubMed ID: 8259256
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drug costs should be lower. Hessian colleagues beaten without compassion].
    MMW Fortschr Med; 2004 Jul; 146(27-28):49. PubMed ID: 15526667
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prescription of high-cost medicines in French Hospitals: Regulation and procedures of reimbursement].
    Wilkowsky C; Lenain A; Benbekhaled K; Le Gall MJ; Vignot S
    Bull Cancer; 2016 Apr; 103(4):353-60. PubMed ID: 27017057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cost-effective drug utilization--what can the national drug agency do?].
    Wesenberg GR; Madsen S
    Tidsskr Nor Laegeforen; 2001 Aug; 121(18):2207. PubMed ID: 11572010
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug prescriptions in liver and biliary disease: something more to be done.
    Podda M; Battezzati PM
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):103-5. PubMed ID: 9615276
    [No Abstract]   [Full Text] [Related]  

  • 17. A study of the additional costs of dispensing workers' compensation prescriptions.
    Schafermeyer KW
    Res Social Adm Pharm; 2007 Mar; 3(1):123-36. PubMed ID: 17350561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reimbursement changes for COPD--basis for worry?].
    Andreassen AH; Lehmann S
    Tidsskr Nor Laegeforen; 2007 Jan; 127(2):206-7. PubMed ID: 17237874
    [No Abstract]   [Full Text] [Related]  

  • 19. [Solid euros instead of soft points].
    Schmidt K
    MMW Fortschr Med; 2007 Jun; 149(23):58-9. PubMed ID: 18062581
    [No Abstract]   [Full Text] [Related]  

  • 20. [Variable prescription of opioids to cancer patients in Norway].
    Olsen AS; Ottesen S
    Tidsskr Nor Laegeforen; 2008 May; 128(11):1271-4. PubMed ID: 18511968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.